| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.29 | 2e-09 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.26 | 6e-06 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.21 | 7e-05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.19 | 7e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.3 | 0.0001 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0001 |